Quick10K

⚲

Biologix Hair

Filings

10-Q	2021-03-31	Filed 2021-05-07
10-K	2020-12-31	Filed 2021-03-16
10-Q	2020-09-30	Filed 2020-11-09
10-Q	2020-06-30	Filed 2020-08-06
10-Q	2020-03-31	Filed 2020-05-11
10-K	2019-12-31	Filed 2020-03-16
10-Q	2019-09-30	Filed 2019-11-06
10-Q	2019-06-30	Filed 2019-08-08
10-Q	2019-03-31	Filed 2019-05-09
10-K	2018-12-31	Filed 2019-03-18
10-Q	2018-09-30	Filed 2018-11-09
10-Q	2018-06-30	Filed 2018-08-01
10-Q	2018-03-31	Filed 2018-05-01
10-K	2017-12-31	Filed 2018-02-22
10-Q	2017-09-30	Filed 2017-11-01
10-Q	2017-06-30	Filed 2017-08-02
10-Q	2017-03-31	Filed 2017-05-02
10-K	2016-12-31	Filed 2017-02-22
10-Q	2016-09-30	Filed 2016-11-02
10-Q	2016-06-30	Filed 2016-08-02
10-Q	2016-03-31	Filed 2016-05-03
10-K	2015-12-31	Filed 2016-02-29
10-Q	2015-09-30	Filed 2015-11-09
10-Q	2015-06-30	Filed 2015-07-30
10-Q	2015-03-31	Filed 2015-05-05
10-K	2014-12-31	Filed 2015-03-02
10-Q	2014-09-30	Filed 2014-11-06
10-Q	2014-06-30	Filed 2014-08-08
10-Q	2014-03-31	Filed 2014-05-01
10-K	2013-12-31	Filed 2014-02-28
10-Q	2013-09-30	Filed 2013-11-04
10-Q	2013-06-30	Filed 2013-08-02
10-Q	2013-03-31	Filed 2013-05-03
10-K	2012-12-31	Filed 2013-03-01
10-Q	2012-09-30	Filed 2012-11-02
10-Q	2012-06-30	Filed 2012-08-02
10-Q	2012-03-31	Filed 2012-05-04
10-K	2011-12-31	Filed 2012-03-02
10-Q	2011-09-30	Filed 2011-11-03
10-Q	2011-06-30	Filed 2011-08-04
10-Q	2011-03-31	Filed 2011-05-05
10-K	2010-12-31	Filed 2011-03-04
10-Q	2010-09-30	Filed 2010-11-03
10-Q	2010-06-30	Filed 2010-08-04
10-Q	2010-03-31	Filed 2010-05-05
10-K	2009-12-31	Filed 2010-03-04

Reports

8-K	2020-11-09
8-K	2020-10-30
8-K	2020-08-24
8-K	2020-08-05
8-K	2020-05-21
8-K	2020-05-11
8-K	2020-03-26
8-K	2020-03-16
8-K	2020-01-28
8-K	2019-11-06
8-K	2019-10-08
8-K	2019-08-08
8-K	2019-06-28
8-K	2019-05-10
8-K	2019-05-02
8-K	2019-03-19
8-K	2019-02-22
8-K	2018-11-09
8-K	2018-11-01
8-K	2018-08-16
8-K	2018-08-02
8-K	2018-06-04
8-K	2018-05-10
8-K	2018-05-02
8-K	2018-05-01
8-K	2018-02-22
8-K	2018-02-19

Biologix Hair Financials

TG Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
CNB Financial (CCNE)	450		5.1	1%	3,541	3,244	0	0	39	78	398
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
Timberline Resources (TLR)
Almost Never Films (HLWD)
1st United Bancorp (FUBC)
Manchester United (MANU)				0%	1,497		0	0	0	0	-308
SQL Technologies (SQFL)		18%	1.5	0%	7	30	9	2	0	2	3
2-Track Global (TTG)
GB Sciences (GBLX)	23	-23%	-1.8	-56%	30	16	4	-1	-17	-13	23
Nemaura Medical (NMRD)	158		-32.0	-182%	3	3	0	0	-5	-5	156
Monroe Bank and Trust (MBTF)	232		-6.6	1%	1,327	1,191	0	0	10	16	-107
Solis Tek (SLTK)	44	51%	-25.8	-163%	1	7	2	1	-2	-2	44
Cumulus Media (CMLS)			-94.7	-0%			0	0	0	-11	1,004
Cyclo Therapeutics, Inc. (CYTHW)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	94	109	69	71	53	44	53	39	44	43	53	45	134	111	118	107	101	96	92	96	97	111	102	103	109	105	36	36	62	37	34	36	40	45
Accounts Receivable							97				95				106				90				91				110				128
Inventory	36	35	61	64	70	66	75	79	78	77	71	71	70	70	74	73	73	66	65	66	67	73	66	76	84	82	87	85	85	93	94	100	93	85
PP&E	692	670	746	758	743	744	749	756	758	780	799	812	827	801	791	764	772	750	755	776	792	795	798	847	861	881	771	781	772	778	793	798	795	797
Assets	601	603	779	792	754	738	783	789	799	793	793	809	806	807	789	770	758	664	623	636	642	656	651	768	808	812	756	756	754	691	707	749	730	731
Accounts Payable	65	64	74	78	80	68	82	89	92	88	83	91	84	98	94	98	85	77	84	74	82	88	81	94	96	96	108	107	121	128	113	111	107	104
Long-Term Debt	0		125	122	98	80	128	119	142	138	139	149	150	150	137	149	147	147	104	143	143	143	95	193	187	177	152	141	123	91	102	110	73	68
Liabilities	165	162	382	386	357	331	411	410	431	417	390	392	383	392	417	421	402	383	351	344	336	338	340	449	449	438	412	393	387	362	353	377	342	333
Stockholders' Equity	436	441	397	406	397	407	372	379	368	377	403	416	424	415	372	349	356	282	273	291	306	318	311	319	359	374	344	363	367	329	355	373	388	398


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	201	204	204	220	235	222	233	242	266	243	231	235	237	240	239	234	221	224	217	207	209	208	205	221	247	247	246	259	264
Cost of Revenue							195				197				205				177				177				209
Gross Profit							38				34				34				40				28				37				48
R&D	3	3	3	4	3	3	3	3	3	3	3	3	3	3	3	4	4	4	4	5	5	5	5	5	5	4	4	4	5	5		4	5	5
SG&A	15	18	20	19	21	16	19	18	19	18	18	18	17	17	18	17	22	15	18	20	20	17	19	20	22	21	22	22	21	21		22	24	23
Tax	3	-0	4	4	7	5	7	4	5	3	5	5	4	5	-3	5	1	3	-0	3	1	0	1	2	3	4	-63	5	5	-7		4	4	-0
Net Income	6	13	-0	3	7	7	10	4	1	7	9	8	5	12	13	10	1	7	-6	7	3	12	2	4	44	8	-18	18	15	-34	26	20	14	17


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		21	23	14	13	22	33	9	12	24	32	10	7	20	14	12	7	14	41	5	14	16	14	4	18	32	35	15	57	21		11	57	18
Cash Investing		-2	-186	-9	-3	-11	-53	-10	-24	-19	-24	-10	-8	-9	-11	-7	-6	-9	-9	-7	-11	-12	-12	-100	-14	-11	-1	-1	-8	-11		-13	-11	-2
Cash Financing		-1	124	-4	-27	-20	24	-10	19	-7	3	-7	-0	-1	-4	3	-9	-5	-34	-3	-17	-4	-0	95	-9	-14	-29	-15	-20	-36		4	-42	-9